CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

GlobalData
180 Pages - GLDATA68886
$1,995.00

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Australia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Australia has one of the fastest growing pharmaceutical markets in the world, providing safe and affordable health care to its citizen. The pharmaceutical market in Australia was valued at $10.58B in 2011 and increased at CAGR of 3.3% to $11.69B in 2018. The market is expected to reach $13.33B in 2022. However, the market value in terms of Australian Dollar was AUD$10.26B in 2011 and increased at a CAGR of 6% to AUD$15.65B in 2018. It is expected to reach AUD$19.78B in 2022. The difference is due to currency exchange fluctuations. In 2015, the medical device market in Australia was worth $8.4B, which increased to $9.5B in 2018 at a CAGR of 4.2%. It is expected to reach $11.9B in 2023. The Australian healthcare market is driven by universal healthcare coverage, wide access to government-subsidized medicine, growing elderly population and its associated disease burden, well-defined regulatory guidelines, the usage of substitute drugs and the introduction of a new manufacturing policy.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Australia, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, Pfizer, Astrazeneca, GSK, and Clinuvel) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Abbott, Siemens, Stryker, and Zimmer Biomet)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Australia
- Porter’s five forces analysis for pharmaceutical and medical devices market of Australia
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding the health-tech landscape of the country along with the major health-tech deals
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Australian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Australian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Australian healthcare market

'

Table of Contents
1.1 List of Figures
1.2 List of Tables
2 Executive Summary
2.1 Executive Summary - Overview
2.2 Key Highlights
2.3 Key Highlights: Australian Government and Healthcare Initiatives, 2019
2.4 Key Highlights: Healthcare Startups in Australia
2.5 Key Events: Australia Healthcare Services History, 2011-2018
2.6 Key Events: Australia Pharmaceutical Market
2.7 Key Events: Australia Healthcare Deals History, 2014-2019
2.8 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2018-2019
2.9 Key Events: Mergers and Acquisitions
2.10 Country Profile, Australia, 2019
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels
3.5 Pharmaceutical Market - Market Segments
3.6 Pharmaceutical Market - Major Therapeutic Areas
3.7 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Top Five Segments
4.3 Medical Device Market - Diagnostic Market
4.4 Medical Device Market - Major Players
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal analysis
6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Australia
6.2 Deal Analysis: M&A, VF and PE Deals, Medical Device Market, Australia
7 Pharmaceutical and Medical Device Market - Porter’s Five Forces Analysis
7.1 Pharmaceutical Market, Australia - Porter’s Five Forces Analysis
7.2 Medical Device Market, Australia - Porter’s Five Forces Analysis
8 Market Access
8.1 Overview of Healthcare System, Australia
8.2 Reimbursement Process, Australia
8.2.1 Reimbursement Process for Pharmaceutical Products, Australia
8.2.2 Reimbursement Process for Medical Devices Products, Australia
8.2.3 Overview of Insurance Providers, Public Health Insurance, Australia
8.2.4 Overview of Insurance Providers, Private Health Insurance, Australia
8.2.5 Healthcare Spending and Price Trends in the Healthcare Sector, Australia
8.2.6 Pricing Policies, Australia
8.3 Regulatory Landscape, Australia
8.3.1 Market Authorization for Pharmaceutical Products, Australia
8.3.2 Market Authorization for Medical Devices, Australia
8.3.3 Licensing Process for Pharmaceutical and Medical Device Manufacturing, Australia
8.3.4 Licensing Process for Pharmaceutical Exports and Imports, Australia
8.3.5 Intellectual Property Rights, Patent, Australia
8.3.6 Intellectual Property Rights, Trademark, Australia
8.3.7 Pharmaceutical Clinical Trials Landscape, Australia
8.3.8 Medical Devices Clinical Trials Landscape, Australia
8.3.9 Clinical Trial Regulation Process, Australia
8.3.10 Pharmaceutical Advertising Regulations, Australia
8.3.11 Pharmacy Regulation, Australia
8.3.12 Labeling and Packaging Regulations, Australia
9 HealthTech Landscape
9.1 HealthTech Deals Landscape, Australia
9.2 Key HealthTech Deals, Australia
9.3 Adoption of Technology in Healthcare, Australia
9.4 Regulatory Scenario Covering Use of Technology in Healthcare
9.5 HealthTech Landscape- Australia- Benefits and Risks
10 Country Healthcare Landscape
10.1 Healthcare Policy Highlights
10.2 Healthcare Facilities
10.3 Healthcare Parameters
10.4 Life Expectancy and Immunization Rate
10.5 Environmental Health
10.6 Healthcare Personnel
10.7 Disease Burden
10.8 Healthcare Expenditure
10.8.1 Healthcare Expenditure - Overview
10.8.2 Share of Public and Private Sectors
11 Trade Associations
12 Trade Fairs, Australia
13 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.1.4 Expert Panel
13.2 Bibliography
13.3 Contact Us
13.4 Disclaimer

List of Tables
Table 1: Pharmaceutical Market, Australia, Pharmacy and Wholesale Mark-up (%), 2019
Table 2: Export and Import ($B) in Medical Device Market, Australia, 2018
Table 3: Medical Device Market, Australia, Revenue by Segment ($B), 2018
Table 4: Ophthalmic Devices Market, Australia, Revenue and Market Share of Major Players
Table 5: Orthopedic Devices Market, Australia, Revenue and Market Share of Major Players
Table 6: InVitro Diagnostics Devices Market, Australia, Revenue and Market Share of Major Players
Table 7: Cardiovascular Devices Market, Australia, Revenue and Market Share of Major Players
Table 8: General Surgery Devices Market, Australia, Revenue and Market Share of Major Players
Table 9: Annual Charges for Prescription Medicines ($), Australia, 2019
Table 10: Application and Evaluation Fees for Prescription Medicines, Australia, 2019
Table 11: Priority review pathway for prescription medicines, Australia, 2019
Table 12: Provisional approval pathway for prescription medicines I, Australia, 2019
Table 13: Provisional approval pathway for prescription medicines II, Australia, 2019
Table 14: Permitted ingredients for listed complementary medicines, Australia, 2019
Table 15: Annual charge for assessed listed medicines, Australia, 2019
Table 16: Assessed listed applications , Australia, 2019
Table 17: Evaluation Fees for New Substance Applications, Australia, 2019
Table 18: Variations to assessed listed medicines (Sector 23 applications), Australia, 2019
Table 19: Variations to assessed listed medicines (Sector 9D applications), Australia, 2019
Table 20: Classification of Medical Devices, Market Access, Australia, 2017
Table 21: Medical Devices Fees, Australia, 2019
Table 22: Annual charges for manufacturing licences, Australia, 2019
Table 23: Australian manufacturing licences, Australia, 2019
Table 24: Overseas manufacturing site inspections, Australia, 2019
Table 25: GMP clearance fees, Market Access, Australia, 2019
Table 26: Issuing manufacturing certificates, Market Access, Australia, 2019
Table 27: Medicine export certificates, Market Access, Australia, 2019
Table 28: Listed export-only medicines , Market Access, Australia, 2019
Table 29: Device export certificates, Market Access, Australia, 2019
Table 30: Export-only devices, Market Access, Australia, 2019
Table 31: Patent Fees (Part I), Australia, 2019
Table 32: Patent Fees (Part II), Australia, 2019
Table 33: Patent Fees (Part III), Australia, 2019
Table 34: Trade Associations, Australia
Table 35: Trade Fairs, Australia

List of Figures
Figure 1: Pharmaceutical Market, Australia, Revenue, 2015-2021
Figure 2: Medical Device Market, Australia, Revenue, 2015-2021
Figure 3: Australian Government and Healthcare Initiatives, Australia, 2019
Figure 4: Healthcare Startups in Australia, Australia, 2019
Figure 5: Key Events: Australia Healthcare Services History, 2011-2018
Figure 6: Australia Healthcare Deals History, 2014-2019, Australia, 2019
Figure 7: Number of Deals (2017-2018)
Figure 8: 2017-2018 Deal Overview By Region
Figure 9: Country Profile, Australia, 2018
Figure 10: Pharmaceutical Market, Australia, Revenue, 2010-2018
Figure 11: Pharmaceutical Market, Australia, Revenue Forecast, 2019-2022
Figure 12: Pharmaceutical Market, Australia, Pharmaceutical Exports, 2018
Figure 13: Pharmaceutical Market, Australia, Top Export Partners, 2018
Figure 14: Pharmaceutical Market, Australia, Pharmaceutical Imports, 2018
Figure 15: Pharmaceutical Market, Australia, Top Import Partners, 2018
Figure 16: Pharmaceutical Market, Distribution Channels, Pharmaceutical Market, Australia, 2018
Figure 17: Pharmaceutical Market, Electronic Transfer of Prescription (eTP), Australia, 2018
Figure 18: Pharmaceutical Market, Biosimilars Approvals, Australia, 2010-2019
Figure 19: Pharmaceutical Market, OTC Product Group Sales ($M), Australia, 2015-2018
Figure 20: Top Selling Drugs by Therapeutic Areas by Value ($M), Australia, 2015
Figure 21: Top Selling Drugs by Therapeutic Areas by Volume (million units), Australia, 2015
Figure 22: Pharmaceutical Market, Australia, Major Players
Figure 23: Medical Device Market, Australia, Revenue, 2015-2018
Figure 24: Medical Device Market, Australia, Revenue Forecast, 2019-2023
Figure 25: Export and Import ($B) in Medical Device Market, Australia, 2018
Figure 26: Medical Device Market, Australia, Revenue by Segment, 2018
Figure 27: Ophthalmic Devices Market, Australia, Revenue
Figure 28: Ophthalmic Devices Market, Australia, Market Share of Major Players
Figure 29: Orthopedic Devices Market, Australia, Revenue
Figure 30: Orthopedic Devices Market, Australia, Market Share of Major Players
Figure 31: InVitro Diagnostics Devices Market, Australia, Revenue
Figure 32: InVitro Diagnostics Devices Market, Australia, Market Share of Major Players
Figure 33: Cardiovascular Devices Market, Australia, Revenue
Figure 34: Cardiovascular Devices Market, Australia, Market Share of Major Players
Figure 35: General Surgery Devices Market, Australia, Revenue
Figure 36: General Surgery Devices Market, Australia, Market Share of Major Players
Figure 37: Diagnostic Market, Australia, Revenue ($B), 2015-2018
Figure 38: Diagnostic Market, Australia, Revenue Forecast ($B), 2019-2023
Figure 39: Medical Device Market, Australia, Revenue of Major Players, 2018
Figure 40: Deal Value and Deal Count, Pharmaceutical Market, Australia, 2018-2019
Figure 41: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Australia, 2018-2019
Figure 42: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Australia, 2018-2019
Figure 43: Top Five Therapy Area by Deal Value, Pharmaceutical Market, Australia, 2018-2019
Figure 44: Top Five Therapy Area by Deal Number, Pharmaceutical Market, Australia, 2018-2019
Figure 45: M&A Deals by Therapy Area, Pharmaceutical Market, Australia, 2018-2019
Figure 46: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Australia, 2018-2019
Figure 47: Private Equity Deals by Therapy Area, Pharmaceutical Market, Australia, 2018-2019
Figure 48: Medical Device Market Deals, Australia 2018-2019 (by Deal Value, $M)
Figure 49: Medical Device Market Deals, Australia, 2018- 2019 (by Deal Count)
Figure 50: Medical Device Deals Share (by Deal Count), Australia, 2018-2019
Figure 51: Medical Device Deals Share (by Deal Value), Australia, 2018- 2019
Figure 52: Medical Device, Top Therapy Area by Deal Value, Australia, 2018-2019
Figure 53: Medical Device, Top Therapy Area by Deal Number, Australia, 2018-2019
Figure 54: M&A Deals by Therapy Area, Medical Device, Australia, 2018-2019 (by Value and by Number)
Figure 55: Venture Financing Deals by Therapy Area, Medical Device, Australia, 2018-2019 (by Value and by Number)
Figure 56: Private Equity Deals by Therapy Area, Medical Device, Australia, 2018-2019 (by Value and by Number)
Figure 57: Deal Value, HealthTech, Australia, 2018-2019
Figure 58: Deal Count, HealthTech, Australia, 2018-2019
Figure 59: Adoption of Technology in Healthcare, Australia, 2019
Figure 60: Organization of HealthCare System in Australia, Market Access, Australia, 2018

$1,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838